论文信息 - Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide - 字舞流文

Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide

D. Petrylak | M. Fleming | R. Cathomas | J. Bothos | Pablo Martinez | J. D. de Bono | A. Rosenbaum | S. Cho | Judy S. Wang | K. Vashisht | M. Liang | M. Hinrichs | Marna B. Williams | P. He | Qu Zhang | M. Miralles